Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous iron to treat anaemia following critical care
ISRCTN13721808Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Sep 2018
- Modality
- Small Molecules
01
Overview
Phase 2 trial of ferric carboxymaltose, sponsored by University of Oxford. Started Sep 2018; status: completed.
02
Drugs
ferric carboxymaltose
Beyond the preview
Go deeper on ISRCTN13721808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13721808.